Related references
Note: Only part of the references are listed.Serum soluble transferrin receptor levels are independently associated with homeostasis model assessment of insulin resistance in adolescent girls
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2023)
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis
Alessandro Mantovani et al.
GUT (2022)
COMPARISON OF FOUR ROUTINELY USED VITAMIN D AUTOMATED IMMUNOASSAYS
Jindra Windrichova et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2021)
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
Rajiv Heda et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease
Aleksandra Klisic et al.
SCIENTIFIC REPORTS (2021)
The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study
Milena Cojic et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Factorial Analysis of the Cardiometabolic Risk Influence on Redox Status Components in Adult Population
Aleksandra Klisic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Vitamin D receptor targets hepatocyte nuclear factor 4? and mediates protective effects of vitamin D in nonalcoholic fatty liver disease
Hong Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2020)
The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders
Izabela Szymczak-Pajor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Association Between Vitamin D and Hyperuricemia Among Adults in the United States
Yi-Ying Zhang et al.
FRONTIERS IN NUTRITION (2020)
Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
Ilaria Barchetta et al.
NUTRIENTS (2020)
A novel mechanism of vitamin D anti-inflammatory/antioxidative potential in type 2 diabetic patients on metformin therapy
Milena Cojic et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
The association between follicle stimulating hormone and glutathione peroxidase activity is dependent on abdominal obesity in postmenopausal women
Aleksandra Klisic et al.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY (2018)
Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yanting Yu et al.
ANNALS OF NUTRITION AND METABOLISM (2018)
The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress Among Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Maryam Akbari et al.
HORMONE AND METABOLIC RESEARCH (2018)
Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes
Amy E. Riek et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data
Behnam Saberi et al.
WORLD JOURNAL OF HEPATOLOGY (2018)
Bioavailable testosterone is independently associated with Fatty Liver Index in postmenopausal women
Aleksandra Klisic et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis
Malgorzata Jamka et al.
EUROPEAN JOURNAL OF NUTRITION (2016)
Associations between Vitamin D and Cardiovascular Disease Risk Factors in African Americans Are Partly Explained by Circulating Adipokines and C-Reactive Protein: The Jackson Heart Study
Rumana J. Khan et al.
JOURNAL OF NUTRITION (2016)
Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients
Rodolphe Anty et al.
OBESITY SURGERY (2016)
Does vitamin D supplementation alter plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials
Madalina Dinca et al.
PHARMACOLOGICAL RESEARCH (2016)
Effect of Vitamin D3 Supplementation on Inflammatory Markers and Glycemic Measures among Overweight or Obese Adults: A Systematic Review of Randomized Controlled Trials
Aleksandra Zuk et al.
PLOS ONE (2016)
The effect of some medications given to CKD patients on vitamin D levels
Claudia Yuste et al.
NEFROLOGIA (2015)
Serum 25-hydroxyvitamin D level is associated with aortic distensibility and left ventricle hypertrophy in newly diagnosed type 2 diabetes mellitus
Osman Kuloglu et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Decreased circulating 25-(OH) Vitamin D concentrations in obese female children and adolescents: Positive associations with Retinol Binding Protein-4 and Neutrophil Gelatinase-associated Lipocalin
Dimitra Metheniti et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2013)
Vitamin D compounds and diabetic nephropathy
L. A. Plum et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects
Rolf Jorde et al.
CYTOKINE (2010)
25-Hydroxyvitamin D Levels, Race, and the Progression of Kidney Disease
Michal L. Melamed et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
25-hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)
Ian H. de Boer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight
MF McCarty et al.
MEDICAL HYPOTHESES (2003)
Share Paper
